DNA aptamers for pancreatic cancer detection
US12398395B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 8, 2019 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | Jul 6, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/115
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided are DNA aptamers selected from a DNA library using Cell-SELEX to bind specifically to cancer cells, which are optimized for high binding affinity to cancer cells can be effectively used for the diagnosis of cancer as they have enhanced targeting efficiencies for target cells and tissues as well as high serum stability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.